Correlation Between Crispr Therapeutics and Albemarle Corp

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Crispr Therapeutics and Albemarle Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Crispr Therapeutics and Albemarle Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Crispr Therapeutics AG and Albemarle Corp, you can compare the effects of market volatilities on Crispr Therapeutics and Albemarle Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Crispr Therapeutics with a short position of Albemarle Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Crispr Therapeutics and Albemarle Corp.

Diversification Opportunities for Crispr Therapeutics and Albemarle Corp

0.17
  Correlation Coefficient

Average diversification

The 3 months correlation between Crispr and Albemarle is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Crispr Therapeutics AG and Albemarle Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Albemarle Corp and Crispr Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Crispr Therapeutics AG are associated (or correlated) with Albemarle Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Albemarle Corp has no effect on the direction of Crispr Therapeutics i.e., Crispr Therapeutics and Albemarle Corp go up and down completely randomly.

Pair Corralation between Crispr Therapeutics and Albemarle Corp

Given the investment horizon of 90 days Crispr Therapeutics AG is expected to under-perform the Albemarle Corp. In addition to that, Crispr Therapeutics is 1.3 times more volatile than Albemarle Corp. It trades about -0.02 of its total potential returns per unit of risk. Albemarle Corp is currently generating about 0.02 per unit of volatility. If you would invest  27,278  in Albemarle Corp on September 5, 2022 and sell it today you would earn a total of  1,150  from holding Albemarle Corp or generate 4.22% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Crispr Therapeutics AG  vs.  Albemarle Corp

 Performance (%) 
       Timeline  
Crispr Therapeutics 
Crispr Performance
0 of 100
Over the last 90 days Crispr Therapeutics AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm insiders.

Crispr Price Channel

Albemarle Corp 
Albemarle Performance
3 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Albemarle Corp are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat conflicting essential indicators, Albemarle Corp may actually be approaching a critical reversion point that can send shares even higher in January 2023.

Albemarle Price Channel

Crispr Therapeutics and Albemarle Corp Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Crispr Therapeutics and Albemarle Corp

The main advantage of trading using opposite Crispr Therapeutics and Albemarle Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Crispr Therapeutics position performs unexpectedly, Albemarle Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Albemarle Corp will offset losses from the drop in Albemarle Corp's long position.
Crispr Therapeutics vs. Aurora Cannabis
Crispr Therapeutics vs. Agilent Technologies
Crispr Therapeutics vs. Acer Therapeutics
The idea behind Crispr Therapeutics AG and Albemarle Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Albemarle Corp vs. Alto Ingredients
Albemarle Corp vs. Air Products And
Albemarle Corp vs. Cabot
Albemarle Corp vs. Chemours Co
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Complementary Tools

Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go